Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $2.162 million which missed the analyst consensus estimate of $2.252 million by 4.00 percent. This is a 3.14 percent decrease over sales of $2.232 million the same period last year.